38 Results for "

1040

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "1040" in MCE Product Catalog:

29
29 Publications Verification
Cat. No.: HY-B0284
CAS No.: 21829-25-4
Synonyms: BAY-a-1040
Research Areas:  

Cardiovascular Disease Cancer

Nifedipine (BAY-a-1040) is a potent calcium channel blocker and agent of choice for cardiac insufficiencies.
loading...
    loading...
23
23 Cited Publications
Cat. No.: HY-50295
CAS No.: 212631-79-3
Synonyms: PD 184352
Target:  

MEK Apoptosis

Research Areas:  

Cancer

CI-1040 (PD 184352) is an orally active, highly specific, small-molecule inhibitor of MEK with an IC50 of 17 nM for MEK1.
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-122844
CAS No.: 1227948-82-4
Purity:  99.66%
Synonyms: BI-853520; IN-10018
Target:  

FAK

Research Areas:  

Cancer

Ifebemtinib (BI 853520) is an orally active and potent focal adhesion kinase (FAK) inhibitor (recombinant FAK IC50=1 nM). Ifebemtinib shows anti-proliferative activity against cancer cells. Ifebemtinib inhibits FER Kinase and FES Kinase with IC50s of 900 nM and 1040 nM, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-11103
CAS No.: 210421-74-2
Purity:  98.83%
Synonyms: IPI 1040 sodium; TBC11251 sodium
Sitaxsentan sodium (IPI 1040 sodium; TBC11251 sodium) is a potent, selective and orally active endothelin A receptor (ETA) antagonist with an IC50 of 1.4 nM and a Ki of 0.43 nM. Sitaxsentan sodium exhibits an IC50 for the ETB receptor of as high as 9800 nM. Sitaxsentan sodium is metabolized by CYP2C9 and CYP3A4, normalizes shunt-induced endothelial abnormalities, restores BMPR signaling, and suppresses pulmonary vascular remodeling and hemodynamic deterioration. Sitaxsentan sodium can be applied in the research of pulmonary arterial hypertension and portopulmonary hypertension .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-76520
CAS No.: 184036-34-8
Synonyms: IPI 1040; TBC-11251
Sitaxsentan (IPI 1040 sodium; TBC11251 sodium) is a potent, selective and orally active endothelin A receptor (ETA) antagonist with an IC50 of 1.4 nM and a Ki of 0.43 nM. Sitaxsentan exhibits an IC50 for the ETB receptor of as high as 9800 nM. Sitaxsentan is metabolized by CYP2C9 and CYP3A4, normalizes shunt-induced endothelial abnormalities, restores BMPR signaling, and suppresses pulmonary vascular remodeling and hemodynamic deterioration. Sitaxsentan can be applied in the research of pulmonary arterial hypertension and portopulmonary hypertension .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-B1040
CAS No.: 19368-18-4
Target:  

Bacterial

Research Areas:  

Infection

Ftaxilide is a novel antituberculosis agent.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-158101
CAS No.: 2446928-30-7
Purity:  99.92%
Synonyms: CC-94676
Research Areas:  

Cancer

BMS-986365 (CC-94676) is an orally active and selective targeted androgen receptor (AR) PROTAC degrader (DC50 of 10-40 nM). BMS-986365 is capable of inducing cereblon (CRBN) E3 ligase-dependent ubiquitination and degradation of the androgen receptor (AR), as well as various AR mutants. BMS-986365 shows no degradation of the close AR family members estrogen receptor (ER), progesterone receptor (PR), and glucocorticoid receptor (GR). BMS-986365 shows significant in vivo potency, degrading AR, inhibiting AR signaling, and restricting tumor growth in animal models of advanced prostate cancer. BMS-986365 can be used for the study of metastatic castration-resistant prostate cancer (mCRPC) .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-101359
CAS No.: 182485-36-5
Purity:  98.1%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

TPMPA, a hybrid of isoguvacine and 3-APMPA, is the first selective antagonist for a GABAC receptor (KB = 2.1 μM), but not to interact with GABAA (KB = 320 μM) or GABAB receptors (EC50 = 500 μM). TPMPA has the potential for the research of suppressing orientation selectivity in ganglion cells .
loading...
    loading...
Cat. No.: HY-DY1040
CAS No.: 231946-72-8
LysoTracker Red (solution) is a Red fluorescently labeled lysosomal probe with a maximum excitation/emission wavelength of 577/590 nm. The structure is composed of a fluorescein group and linked weak bases, which can freely cross the cell membrane and gather on spherical organelles. It is suitable for observing the internal biosynthesis and related pathogenesis of lysosomes .
Solvent and concentration: DMSO: 1 mM
loading...
    loading...
Cat. No.: HY-D1040
CAS No.: 1449612-07-0
Synonyms: Cyanine 5.5 carboxylic acid
Cy5.5-COOH (Cyanine 5.5 carboxylic acid) is a fluorescent dye that emits fluorescence at 710 nm upon excitation at 650 nm. Cy5.5-COOH possesses excellent spectral properties, including a narrow absorption spectrum, high sensitivity, and stability. Cy5.5-COOH can be used for bioimaging and disease diagnosis .
loading...
    loading...
Cat. No.: HY-D1040A
CAS No.: 2410537-32-3
Synonyms: Cyanine 5.5 carboxylic acid chloride
Cy5.5-COOH (Cyanine 5.5 carboxylic acid) chloride is a fluorescent dye that emits fluorescence at 710 nm upon excitation at 650 nm. Cy5.5-COOH chloride possesses excellent spectral properties, including a narrow absorption spectrum, high sensitivity, and stability. Cy5.5-COOH chloride can be used for bioimaging and disease diagnosis .
loading...
    loading...
Cat. No.: HY-N1040
CAS No.: 61597-83-9
Target:  

Others

Research Areas:  

Others

13-Hydroxy-8,11,13-podocarpatriene-18-oic acid is a compound isolated from the bark of Pinus yunnanensis Franch .
loading...
    loading...
Cat. No.: HY-139558
CAS No.: 303175-44-2
Purity:  99.85%
Synonyms: PD0184264; ATR-002
Research Areas:  

Infection Cancer

Zapnometinib (PD0184264), an active metabolite of CI-1040, is a MEK inhibitor, with an IC50 of 5.7 nM. Zapnometinib exhibits antiviral activity against influenza virus and antibacterial activities .
loading...
    loading...
Cat. No.: HY-101918
CAS No.: 1335138-89-0
Purity:  99.51%
Target:  

Thrombin

Research Areas:  

Cardiovascular Disease

DS-1040 Tosylate is an orally active, selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (TAFIa) with IC50s of 5.92 nM and 8.01 nM for human and rat TAFIa. DS-1040 Tosylate is a fibrinolysis enhancer for thromboembolic diseases .
loading...
    loading...
Cat. No.: HY-B0284S
CAS No.: 1188266-14-9
Synonyms: BAY-a-1040-d6
Nifedipine-d6 (BAY-a-1040-d6) is deuterium labeled nifedipine, and nifedipine is a potent calcium channel blocker.
loading...
    loading...
Cat. No.: HY-169784
CAS No.: 1436673-69-6
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

PPI-1040 is an orally bioavailable vinyl ether synthetic plasmalogen. PPI-1040 acts as a precursor of plasmalogen. PPI-1040 increases plasmalogen levels in plasmalogen-deficient mice and normalizes hyperactive behaviors in these mice. In wild-type mice, PPI-1040 retains the sn-1 vinyl ether group and sn-3 phosphoethanolamine group, and is converted into endogenous ethanolamine plasmalogen. PPI-1040 can be used in studies related to rhizomelic chondrodysplasia punctata .
loading...
    loading...
Cat. No.: HY-B0284R
CAS No.: 21829-25-4
Synonyms: BAY-a-1040 (Standard)
Nifedipine (Standard) is the analytical standard of Nifedipine. This product is intended for research and analytical applications. Nifedipine (BAY-a-1040) is a potent calcium channel blocker and agent of choice for cardiac insufficiencies.
loading...
    loading...
Cat. No.: HY-W019726
CAS No.: 67035-22-7
Synonyms: BAY-b 4759
Target:  

Drug Metabolite

Research Areas:  

Cardiovascular Disease Cancer

Dehydro nifedipine (BAY-b 4759) is a metabolite of Nifedipine (HY-B0284). Nifedipine (BAY-a-1040) is a potent calcium channel blocker and an agent of choice for cardiac insufficiencies .
loading...
    loading...
Cat. No.: HY-P1822
CAS No.: 329696-49-3
Research Areas:  

Metabolic Disease

BDC2.5 mimotope 1040-31, a BDC2.5 TCR reactive peptide, is a strong agonistic peptide for diabetogenic T cell clone BDC2.5, and the 1040-31 peptide is specific for BDC 2.5 TCR Tg + T cells .
loading...
    loading...
Cat. No.: HY-135356
CAS No.: 21881-77-6
Purity:  99.76%
Target:  

Drug Metabolite

Research Areas:  

Cardiovascular Disease

m-Nifedipine is an impurity of Nifedipine (BAY-a-1040). Nifedipine is a potent calcium channel blocker and agent of choice for cardiac insufficiencies .
loading...
    loading...